Pharma fonden ApS: Financial statements 2025
CVR: 45423859
Source: annual report 2025, Danish Business Authority
25/02/2025 – 31/12/2025
Pharma fonden ApS (CVR 45423859) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -2,129 and a net result of DKK -2,129. Equity in the 2025 report amounted to DKK 785,871. The solvency ratio was 100%.
- Gross Profit
- DKK -2,129
- Profit/Loss
- DKK -2,129
- Equity
- DKK 785,871
- Total Assets
- DKK 785,871
- Employees
- 0
Official annual report
How creditworthy is Pharma fonden ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of March 21, 2025, is registered as an owner of Pharma fonden ApS with an ownership share of 10%.
As of February 25, 2025, Kristian Worziger Nielsen is registered as director of Pharma fonden ApS.
As of February 25, 2025, Kristian Worziger Nielsen is registered as an owner of Pharma fonden ApS with an ownership share of 66%.
Pharma fonden ApS was founded on February 25, 2025.
About Pharma fonden ApS
Pharma fonden ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2025. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Kristian Worziger Nielsen. The company is owned by Kristian Worziger Nielsen and Sara Marie Arambula. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -2,129 and a net result of DKK -2,129. Equity in the 2025 report amounted to DKK 785,871.
